Green Spring Recognizes Omicron - Statement Omicron

The German pharmacist newspaper also put the Corona Rapid Test Green Spring SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold) (Shenzhen Lvshiyuan Biotechnology Co., Ltd.), which we imported directly from the factory, in first place on the list of tests with very high Sensitivity. (https://www.deutsche-apotheker-zeitung.de/news/artikel/2021/11/10/die-20-besten-antigenschnelltests-laut-pei/chapter:2)
96 tests passed the examination.
Of these, Green Spring shows the highest sensitivity.
Here, sensitivity means the ability to detect not only large amounts of viruses, but also small traces of corona viruses right at the beginning of an infection.
This is becoming so important at OMIKRON and in early detection. For this purpose, the virus load must lead to a correct measurement result, even with a lower virus quantity. Likewise, when an infection ends, it should be carefully checked again that the infection is really over and over.

We are factory authorized direct importers. You can contact us with any questions about supplying the best Test Antigen Rapid Test Kit Colloidal Gold.

"The WHO held on 26 An emergency meeting to discuss the recently discovered mutant strain of the novel coronavirus B.1.1.529 on November 1, 2021. After the meeting, the WHO issued a statement declaring B.1.1.529 to be a "variant of concern" labeled Omicron. The variant B.1.1.529 was first reported to the WHO on 24 November 2021 from South Africa, and the first sample infected with the mutant strain was reported on November 9, 2021. Taken November, the WHO said in a statement.
This variant has a large number of mutations, some of which are worrying.

The SARS-CoV-2 Antigen Rapid Test Kit, manufactured by Shenzhen Lvshiyuan
Biotechnology Co., Ltd., is used for the in vitro qualitative detection of SARS-CoV-2 virus using
Nucleocapsid (N) protein in human nasopharynx, oropharynx, anterior-nasal or
saliva samples.
It can be seen, the mutation sites of mutant virus strains, including the Omicron strain, do not affect the detection rate of the kits we produce.
The kit is suitable for the assay of the SARS-CoV-2 virus variant called "Omicron".
The SARS-CoV-2 Antigen Rapid Test Kit, manufactured by Shenzhen Lvshiyuan
Biotechnology Co.,Ltd. is used for the qualitative in vitro detection of the SARS-CoV-2 virus
Nucleocapsid (N) protein in human nasopharynx, oropharynx, anterior-nasal, or salivary specimens.
It can be seen that the mutation sites of mutant virus strains, including the Omicron strain, do not affect the detection rate of the kits we produce. The kit is suitable for the assay of the SARS-CoV-2 virus variant called "Omicron".

Preliminary studies suggest that this Omicron variant causes an increased risk of reinfection in humans compared to other "concerning" variants. The number of cases of this variant seems to be increasing in almost all provinces of South Africa.
According to reliable reports, since the outbreak of the SARS-CoV-2 virus, there have been at least hundreds of mutations in the gene sequence, all of which have resulted in the virus becoming more infectious and pathogenic. Among the best known of these strains are Alpha, which first appeared in Kent, England, Beta in South Africa, Gamma in Brazil, Delta in India, and Mu, first discovered in Colombia and certified by the WHO on March 30, 2018. officially named Aug. And Omicron, recently discovered in South Africa.
The omicron variant of the virus has been hitting many countries and regions around the world with its strong infectivity and pathogenicity lately. The novel coronavirus (SARS-CoV-2 or 2019-nCoV) is a non-segmented forward RNA virus. It is the cause of the new type of coronavirus pneumonia (COVID-19), which is highly contagious in humans.
The SARS-CoV-2 virus has several structural proteins including spike (S), envelope (E), membrane (M) and nucleocapsid (N).
The SARS-CoV-2 virus is characterized by high stability of the nucleocapsid protein (N).
The mutant virus strains found worldwide are descended from the evolutionary strain SARS-CoV-2 20B/GR (lineage B.1.1.7), which contains many mutations.
The site of the mutation is the spike protein (S) of the new coronavirus, which is the site where the SARS-CoV-2 virus attaches itself to the cell's ACE2 receptor.

The SARS-CoV-2 Antigen Rapid Test Kit, manufactured by Shenzhen Lvshiyuan Biotechnology Co., Ltd. is used for the in vitro qualitative detection of SARS-CoV-2 virus to detect nucleocapsid (N) protein in human nasopharynx, oropharynx, anterior nasal or salivary specimens.

It can be seen, the mutation sites of mutant virus strains, including the Omicron strain, do not affect the detection rate of the kits we produce. The kit is suitable for the assay of the SARS-CoV-2 virus variant called "Omicron".